Zygmont Chester Stanley III 4
4 · REVELATION BIOSCIENCES, INC. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Zygmont Chester Stanley III
Chief Financial Officer
Transactions
- Award
Common Stock
[F1][F2]2026-01-08$0.90/sh+78,145$70,331→ 473,790 total(indirect: By Trust)
Holdings
- 395,640(indirect: By Trust)
Common Stock
[F2] - 5(indirect: By LLC)
Common Stock
[F3]
Footnotes (3)
- [F1]Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.
- [F2]Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
- [F3]Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III|2026-01-08